Loss of heterozygosity

From WikiMD's WELLNESSPEDIA

Loss of heterozygosity (LOH) is a genetic event that results in the loss of the normal function of one allele of a gene where the other allele was already inactivated. It is a common occurrence in cancer and is thought to play a key role in its development and progression.

Overview[edit]

LOH can occur through several mechanisms, including deletion, mutation, and uniparental disomy. It is a common event in cancer, where it can lead to the inactivation of tumor suppressor genes and contribute to the development and progression of the disease.

Mechanisms[edit]

There are several mechanisms through which LOH can occur. These include:

  • Deletion: This occurs when a portion of the DNA is lost during replication. If the deleted region contains a tumor suppressor gene, this can lead to the development of cancer.
  • Mutation: A mutation can inactivate a gene, leading to LOH if the other allele is already inactivated.
  • Uniparental disomy: This occurs when an individual inherits two copies of a chromosome from one parent and none from the other. If the duplicated chromosome contains a mutated gene, this can lead to LOH.

Role in Cancer[edit]

LOH is a common event in cancer. It is thought to play a key role in the development and progression of the disease by leading to the inactivation of tumor suppressor genes. These genes normally help to prevent the development of cancer by controlling cell growth and division. When they are inactivated, this can lead to uncontrolled cell growth and the development of cancer.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.